Sunshine Biopharma Inc. (SBFM) KPIs and segments
SBFMNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 10/30
$2.54−0.06 (-2.31%)
Close on Nov 17, 2026Market cap $9.85MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Sunshine Biopharma's business
Coming soon
This tab will track the numbers specific to Sunshine Biopharma's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?